JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliance Certificate
Compliance Certificate (Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) for the half year ended 31ST March, 202220-04-2022
20-04-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st March, 2022.15-04-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Open Offer - Updates
This is to intimate that the company has received the Draft Letter of Offer (DLOF) in relation to the Open Offer.07-03-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Draft Letter of Offer
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the eligible public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").04-03-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Open Offer - Updates
Intimation for Detailed Public Statement Under Regulations 3(1) and 4 read with Regulations 13(4), 14(3) And 15(2) and other applicable provisions of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended28-02-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Updates on Open Offer
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulation 13(4), 14(3), 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the eligible public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").28-02-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Clarification On Price Movement.
Clarification on Price Movement.28-02-2022
Jagsonpal Pharma rallies 19% on open offer by Infinity Holdings Group
Infinity Holdings Group made an open offer to buy 26 per cent stake in the company at a price of Rs 235 per share22-02-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation21-02-2022
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
Intimation for Public Announcement.21-02-2022